Coldstream Capital Management Inc Prothena Corp Public LTD CO Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Coldstream Capital Management Inc holds 51 shares of PRTA stock, worth $388. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51Holding current value
$388% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRTA
# of Institutions
191Shares Held
44.6MCall Options Held
259KPut Options Held
272K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$88.2 Million11.27% of portfolio
-
Wellington Management Group LLP Boston, MA5.2MShares$39.6 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$29.4 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.46MShares$26.3 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$17 Million0.44% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $357M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...